More than half the deals made by pharma are with companies based in the US, 28 percent in Europe, and 15 percent Japan.
Jim Hall
Advertisement
Articles by Jim Hall
Advertisement
Latest Updated Articles
A Decade (and 1/2) of DealsOctober 1st 2004
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Reportedly Pauses National Priority Voucher Pilot and Pauses CRL Publication
2
Zai Lab’s Long-Acting Atopic Dermatitis Bispecific Points to Every-12-Week Dosin
3
What 3 Principles Guide Merck's Biologics and ADC Capacity Placement?
4
FDA Grants Kamau RMAT Designation to Nula-cel for Sickle Cell Disease
5